Previous 10 | Next 10 |
2024-05-12 13:57:40 ET More on the markets SPY ETF: Momentum Is In The Cards SPY: Get Ready For A Recessionary Bear Market SPY: Growing Signs The Market Is Overbought Wells Fargo sees increasing risk that the Fed will need to hold rates at current levels ...
2024-05-11 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-11 03:15:00 ET Shares of Hims & Hers Health (NYSE: HIMS) jumped following the company's first-quarter earnings report that once again announced surging revenue growth. That performance has helped the stock perform well this year, up about 40%. Let's look at some rece...
2024-05-09 07:36:42 ET Summary It's been a wild week for HIMS stock — CEO Andrew Dudum said a few things that upset investors. H&H also reported blowout earnings, sending shares higher. People quickly forget that H&H is a brilliant company. I share with you ...
2024-05-08 10:44:13 ET Summary Hims & Hers is showing strong operating leverage and maintaining high growth, which should continue in future quarters. The CEO's recent tweets on the Israel/Gaza situation are unfortunate from an investor perspective, but the business impact is ...
2024-05-08 08:30:00 ET Growth stocks have resoundingly outperformed value and dividend stocks since the 2008 financial crisis. While this trend is a reversal relative to historical norms, growth stocks are likely to continue to deliver outstanding returns over the long term due to the emerg...
2024-05-08 03:31:58 ET Summary Hims & Hers reported strong Q1 FY24 earnings, with revenue and earnings growing 46% and 434% YoY respectively, as the number of subscribers opting for a personalized product grew 176%. The company is focused on growing its personalized solutions ...
2024-05-07 18:00:04 ET Glen Santangelo from Jefferies issued a price target of $14.00 for HIMS on 2024-05-07 16:03:00. The adjusted price target was set to $14.00. At the time of the announcement, HIMS was trading at $12.35. The overall price target consensus is at $12.8...
2024-05-07 15:35:00 ET Shares of growth stock Hims & Hers Health (NYSE: HIMS) jumped as much as 17.1% in trading on Tuesday after the company reported first-quarter 2024 financial results. As of 3 p.m. ET, shares were holding about an 8.4% gain for the day. Hims & He...
2024-05-07 13:59:04 ET Summary Hims & Hers Health, Inc. is leading in personalized health and building a strong health and wellness platform, leading to strong subscription growth. The company reported profitable growth in Q1 '24, with positive cash flows from adjusted profits...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...